Clinical Trial Update: Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and proof-of-concept results from a Phase 1/2 study of intravesical DTA-H19 in patients with superficial bladder cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• DTA-H19

Snippet

Sponsor: Hebrew University of Jerusalem | Conditions: Bladder Neoplasms | Phase 1, Phase 2 | Status: COMPLETED